Efficacy and Safety of Ultra Small Dose Decitabine for the Lower Risk MDS Patients With Transfusion Dependent
Condition(s):Myelodysplastic SyndromesLast Updated:February 7, 2017Unknown status
Hide Studies Not Open or Pending
Condition(s):Myelodysplastic SyndromesLast Updated:February 7, 2017Unknown status
Condition(s):Liver Metastasis; Colorectal CancerLast Updated:October 27, 2017Completed
Condition(s):Peripheral Blood Stem Cell TransplantationLast Updated:October 20, 2020Recruiting
Condition(s):Myelodysplastic Syndromes; Chronic Myelomonocytic Leukemia; Acute Myeloid LeukemiaLast Updated:January 7, 2021Recruiting
Condition(s):Childhood Solid Tumor; Childhood Lymphoma; Relapsed Cancer; Refractory Cancer; Adult Solid Tumor; Adult LymphomaLast Updated:February 15, 2022Recruiting
Condition(s):Leukemia, Lymphoblastic, Acute; Leukemia, Myeloid Acute; Hematopoetic MyelodysplasiaLast Updated:October 15, 2018Completed
Condition(s):Myelodysplastic Syndrome; Acute Myeloid LeukemiaLast Updated:November 20, 2015Unknown status
Condition(s):Myelodysplastic Syndromes; MDS/MPN Crossover SyndromesLast Updated:August 20, 2021Recruiting
Condition(s):Refractory Aplastic AnemiaLast Updated:May 12, 2021Recruiting
Condition(s):HealthyLast Updated:May 9, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.